|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 | |
| G01N 33/53 |
| (11) | Patento numeris | 2904115 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13843965.8 |
| Europos patento paraiškos padavimo data | 2013-10-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-08-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-08-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/062902 |
| Data | 2013-10-01 |
| (87) | Numeris | WO 2014/055543 |
| Data | 2014-04-10 |
| (30) | Numeris | Data | Šalis |
| 201261708349 P | 2012-10-01 | US |
| (72) |
BLAKEMORE, Stephen, J., US
LI, Bin, US
SHIN, Hyunjin, US
TREPICCHIO, William, L., US
|
| (73) |
Millennium Pharmaceuticals, Inc.,
40 Landsdowne Street, Cambridge, MA 02139,
US
|
| (54) | BIOMARKERS AND METHODS TO PREDICT RESPONSE TO INHIBITORS AND USES THEREOF |
| BIOMARKERS AND METHODS TO PREDICT RESPONSE TO INHIBITORS AND USES THEREOF |